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BRIEF REPORT 
Relationship of Patient Self-Administered COPD 
Assessment Test to Physician Standard Assessment 
of Chronic Obstructive Pulmonary Disease in a Family 
Medicine Residency Training Program 
An estimated 11 million Americans have a diagnosis of chronic obstructive pulmonary disease (COPD), with another 13 million 
potentially affected.1,2 Currently, COPD is ranked as 
the third-leading cause of death in the United States.3 
Certain geographical regions are more impacted by 
COPD due in part to cultural influences and lifestyle 
factors such as smoking and occupational exposure. 
Tennessee has one of the higher percentages of citizens 
diagnosed with COPD, with a current prevalence 
estimate of 8.1% (state range: 3.5%–13.6%).1
Symptoms of COPD are highly variable with 
significantly different presentations between 
patients.4,5 Hallmark symptoms of shortness of 
breath and increased sputum production can often 
overshadow nonspecific symptoms, which may be 
overlooked or not attributed to COPD. Anxiety, 
depression, and difficulty sleeping are often present 
but may not be correlated to COPD by patients 
or providers.6 These symptoms can be difficult to 
measure and often affect activities of daily living as 
well as confidence in simple tasks such as leaving the 
home without fear of worsened symptoms.7
Abstract  Assessing the global impact of chronic obstructive pulmonary disease (COPD) on a patient’s life 
can be difficult to perform in the clinical setting due to time constraints and workflow challenges. 
The primary objective of this study was to compare disease impact ratings between patient self-
administered COPD Assessment Test (CAT) and physician standard office assessment. This 
prospective study was conducted at a family medicine residency clinic in northeast Tennessee. The 
study included two study groups: 1) adult patients seen at the clinic during the 3-month study period 
with an active diagnosis of COPD, and 2) their physicians. Physicians’ assessment of the impact of 
COPD on their patients’ daily lives was compared to patients’ self-administered CAT assessments. 
Physician assessment of COPD impact and patient assessment of CAT categories significantly 
differed (χ2=11.0, P=0.012). There was very poor agreement between patient and physician ratings 
(κ=0.003), with 42.9% of physician ratings underestimating the impact, 28.6% overestimating the 
impact, and 28.6% correctly estimating the impact COPD had on their patients’ lives. These findings 
support the use of validated assessment tools to help providers understand the symptom burden for 
patients with COPD. (J Patient Cent Res Rev. 2019;6:210-215.)
Keywords chronic obstructive pulmonary disease; COPD; assessment test; quality of life; family medicine
Correspondence: Jessica E. Burchette, PharmD,
East Tennessee State University, PO Box 70657,  
Johnson City, TN 37614 (burchettej@etsu.edu)
Brief Report
 www.aurora.org/jpcrr 211Brief Report
Assessing the global impact of COPD on an individual 
patient can be difficult to perform because of time 
constraints and workflow challenges in clinic.8 Also, 
patients may underreport the severity of COPD during 
standard patient-provider interactions due to the 
variability of symptoms over time.9 Given that ample 
data have indicated that spirometry does not directly 
correlate with symptoms,10 the need for a reliable 
assessment tool to measure disease impact is crucial.
Family medicine providers care for a complex 
and diverse patient population with many chronic 
diseases. Utilizing a standard assessment to guide 
the patient discussion can assist providers in 
formulating evidence-based care plans for individual 
patients. These assessments can open discussion 
regarding disease impact on quality of life beyond a 
generic “How are you?” approach.11 Understanding 
and valuing which aspects of a disease are most 
concerning to patients is a cornerstone of patient-
centered care and has an influence on patient-provider 
trust and rapport.12
The COPD Assessment Test (CAT) was developed in 
2009 as a short, patient-administered questionnaire for 
measuring health-related quality of life for patients with 
COPD.13 This assessment was designed for clinical 
practice, taking about 2 to 3 minutes to complete, 
and has been validated in multiple languages.14 Ideally, 
patients would self-administer the CAT prior to an office 
visit as a tool for stimulating discussion. Scores range 
from 0 to 40 and are categorized as low, medium, high, 
or very high impact. The CAT is currently undergoing 
review by an expert governance board to ensure 
usability and reliability for patients everywhere.15
The primary objective of this study was to compare 
disease impact ratings between patient self-administered 
CAT and physician standard office assessment. 
Secondary objectives include whether patient and/or 
physician characteristics impacted COPD assessment 
scoring variations between the two groups.
METHODS
This prospective study was conducted at a family 
medicine residency clinic in northeast Tennessee. 
The study included two groups: 1) adult patients seen 
at the clinic during the 3-month study period with an 
active ICD-10 code consistent with COPD, and 2) 
their physicians. This study was approved by the East 
Tennessee State University institutional review board. 
Informed consent was obtained from all participants. 
The clinic’s social health specialist reviewed a weekly 
report of scheduled appointments and assessed for the 
following inclusion criteria: age of ≥18 years, active 
diagnosis of COPD, English speaking, legally able to 
make personal treatment decisions, and not pregnant at 
the time of the visit. Those with an acute exacerbation 
of COPD within 2 weeks of the visit were excluded. 
Potential patients were highlighted each day prior to 
the start of clinic. All clinic physicians were eligible 
for inclusion. 
Upon completion of the visit, physicians completed 
a 1-item assessment of their perception of whether 
COPD had a low, medium, high, or very high impact 
on their patient’s quality of life (mimicking CAT 
impact categories). Physician gender and experience 
level (resident training year, faculty) were collected. 
Eligible patients were approached by the nurse before 
leaving the examination room to ask about willingness 
to participate. Those willing to participate were 
escorted to the social health specialist’s office, where 
they were consented and asked to complete the CAT. 
Patient demographics, including age, gender, and 
smoking status, were collected. Figure 1 illustrates the 
study workflow.
Descriptive analyses were used to provide summaries 
of patient and physician participant demographic 
characteristics. Patient participants’ CAT scores 
were totaled and categorized by impact on well-
being and daily life (low, medium, high, or very high 
impact). Chi-squared (χ2) tests were used to compare 
physicians’ ratings of COPD impact to their patients’ 
CAT categories, as well as differences in sex, smoking 
status, and physician experience. Cohen’s kappa (κ) 
coefficient was used to compare agreement between 
physician and patient ratings. All analyses were 
conducted using SPSS Statistics, Version 23 (IBM 
Corp, Armonk, NY).
RESULTS
Fifty matched pairs of patient CAT and physician 
assessment forms were collected over 3 months. One 
set was removed due to incomplete data, leaving 49 
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usable sets of matched forms. The majority of the 49 
patient participants were female (61.2%), and the cohort 
averaged 63.5 ± 8.9 years of age. Slightly more than 
half were current smokers (51%). Physician participants 
were more frequently male (55.1%) and third-year 
family medicine residents (40.8%) (Table 1).
There were significant differences between physician 
assessment of COPD impact on patients’ lives 
and patients’ self-assessment of CAT categories 
(χ2=11.0, P=0.012) (Figure 2). Data indicated very 
poor agreement between patient and physician 
ratings (κ=0.003), with 42.9% of physician ratings 
underestimating the impact, 28.6% overestimating 
the impact, and 28.6% correctly estimating the impact 
COPD had on their patients’ lives. Furthermore, 
physicians were more likely to underestimate COPD 
impact for those not currently smoking (50%) versus 
current smokers (36.0%); P=0.047. Although female 
physicians were more likely to correctly assess COPD 
impact (40.9%) than male physicians (18.5%), this was 
not statistically significant (P=0.08). There were no 
significant differences based on physician experience, 
patient sex, or patient age.
DISCUSSION
Implementing a standardized, validated assessment tool 
to monitor chronic disease impact has value for patients 
and providers.9 Our study identified a discrepancy 
between physician assessment of disease impact and 
patient self-reported impact via CAT scoring. One 
explanation for this incongruity is a lack of general 
knowledge among physicians and patients of less well-
described COPD symptoms. Most patients understand 
that shortness of breath, coughing, and sputum production 
are symptoms of COPD; however, other symptoms such 
as anxiety, depression, or poor sleep patterns may not 
be considered COPD-related. Patients with COPD have 
been shown to experience a higher mental health burden 
than patients with other chronic health conditions, and 
the correlation between COPD and mental health has 
been linked to negative effects on mortality, increased 
risk of exacerbations, longer hospital stays, and poorer 
quality of life with decreased functional status.16,17 
During a general patient encounter, the patient may 
not report psychological symptoms when asked about 
the impact of COPD on daily life because of a lack of 
knowledge related to symptom-disease relationship.18 
Clinically, there are significant implications for patients 
to underestimating the impact of COPD, including 
potential undertreatment of symptoms that could lead to 
acute exacerbations, further decreasing quality of life.
Another potentiating factor in the patient-provider 
disease assessment may be variation between individual 
providers related to COPD assessment. For example, 
female physicians are more likely to engage in patient-
centered communication,19,20 suggesting that perhaps 
they are better poised to estimate individual patient 
disease impact. The increased correct assessment of 
COPD impact by female physicians was not statistically 
significant in this pilot study, perhaps due to sample 
size. Nonetheless, as each provider has his or her own 
style of patient interview, the assessment of disease may 
vary based on the types of questions asked and the way 
in which they are posed to the patient. By implementing 
a standardized assessment for COPD impact, patients 
and providers can come to the encounter with common 
ground for assessment and discussion.
The clinical impact of adding a standardized assessment 
of COPD, such as the CAT, to routine care for all 
patients with COPD does not come without added 
 
Study staff confirm 
list of eligible 
patients each week
Nurses notified of 
eligible patients at 
morning huddle
Physician 
completes routine 
office visit
Nurse places physician 
assessment form in eligible 
patient’s exam room door
Physician 
completes 
assessment form
Patient consented 
in private office by 
study staff
Patient completes 
COPD Assessment 
Test
Figure 1.  Chronic obstructive pulmonary disease 
(COPD) assessment study flow.
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time requirements for clinical workflow. Practice 
administrators should evaluate current procedures to 
determine appropriate places within the patient/clinic 
flow to administer these assessments. Patient check-
in is an easily identifiable point in clinic workflow to 
administer an assessment; this procedure would allow 
patients to complete the assessment prior to seeing 
the provider and may prompt patients to generate 
questions regarding their care. To avoid the potential 
of biasing the study, our patients did not complete the 
CAT prior to seeing the provider, but in daily practice 
asking a patient to complete the CAT prior to the 
visit would likely be more beneficial to the patient-
provider discussion.14 Alternatively, asking the nurse 
to provide the CAT to the patient as they are roomed 
could provide more information during the encounter 
without disrupting clinic flow.
This study has many strengths, which support the 
validity of the results in practice. The study was a 
prospective review of real-time provider assessment of 
COPD impact on a patient’s life. The providers were 
instructed to perform their assessment and exam as 
usual and had not been previously educated on the CAT. 
Patient self-assessment of disease impact via the CAT 
is validated in the literature and proven to increase the 
comprehensiveness of patient symptom reporting.9,21 
Having patients complete the CAT after the encounter 
prevented discussion of the questions and results with the 
provider during the visit, helping to reduce study bias.
Although efforts were taken to solidify and strengthen 
this study, there are limitations that should be 
addressed. Due to patient identification methods 
and variation in monthly resident schedules, we were 
 
Physician Agreement With Patient CAT
Characteristic
All, 
n (%)
Same, 
n (%)
Under, 
n (%)
Over, 
n (%) P
COPD impact 14 (28.6) 21 (42.9) 14 (28.6) 0.01
Patient age*
   45–54 years 10 (20.4) 5 (50.0) 4 (40.0) 1 (10.0)
0.36
   55–64 years 14 (28.6) 3 (21.4) 5 (35.7) 6 (42.9)
   65–74 years 20 (40.8) 4 (20.0) 11 (55.0) 5 (25.0)
   75–84 years 5 (10.2) 2 (40.0) 1 (20.0) 2 (40.0)
Patient sex
   Female 30 (61.2) 7 (23.3) 14 (46.7) 9 (30.0)
0.31   Male 19 (38.8) 7 (36.8) 7 (36.8) 5 (26.3)
Physician sex
   Female 22 (44.9) 9 (40.9) 8 (36.4) 5 (22.7)
0.08   Male 27 (55.1) 5 (18.5) 13 (48.1) 9 (33.3)
Patient smoking status
   Current smoker 25 (51.0) 11 (44.0) 9 (36.0) 5 (20.0)
0.05   Former smoker 24 (49.0) 3 (12.5) 12 (50.0) 9 (37.5)
Physician training year
   PGY 1 8 (16.3) 2 (25.0) 4 (50.0) 2 (25.0)
0.47
   PGY 2 18 (36.7) 8 (44.4) 6 (33.3) 4 (22.2)
   PGY 3 20 (40.8) 4 (20.0) 10 (50.0) 6 (30.0)
   Faculty 3 (6.1) 0 (0.0) 1 (33.3) 2 (66.7)
Table 1.  Characteristics of Patients (n=49) and Physicians (n=49) and Their Respective Relationships to 
COPD Impact Agreement
*Mean age for the 49-patient cohort was 63.5 ± 8.9 years. 
CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; PGY, postgraduate year.
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unable to assess the level of provider/patient continuity 
of care. Arguably, a lack of familiarity with the patient 
may have impacted the provider’s ability to assess 
disease impact. Another limitation is the difference in 
assessment methods for comparing patient and provider 
results. Physicians were asked to categorize patients 
directly into 1 of 4 impact categories, whereas patient 
CAT scores were represented numerically as the sum of 
the 8-item Likert scale assessment and then categorized 
by impact. This difference in scoring could have created 
discrepancy between the provider and patient scoring. 
Finally, although we made multiple efforts to reduce 
study bias, it is possible physicians may have been 
alerted to a potential study participant prior to seeing 
the patient, which could have triggered the physician 
to ask additional COPD-related questions. However, 
even with this potential bias, we still found physicians 
underestimated the impact of COPD on patients’ lives.
Future plans include assessing the effect of fully 
implementing the CAT into practice and the impact 
on treatment decisions. As addressed previously, there 
are no available data addressing variation among 
provider styles. Future work that attempts to quantify 
and qualify provider style differences may further 
contribute to the development of reliable standardized 
patient assessments. Much of the future direction 
regarding the widespread use of the CAT within the 
United States will depend on the outcomes from the 
CAT governance board.15
Our results indicated poor agreement between 
physicians’ standard assessment of COPD symptom 
impact on patients’ daily lives and patients’ self-
assessment. These findings support the use of validated 
assessment tools to help providers understand the 
symptom burden for patients with COPD. Family 
medicine providers are uniquely positioned to care for 
patients with many chronic diseases, which includes 
understanding the patients’ perspective on disease and 
the symptom burden impacting daily life. Standardized 
measures of disease impact, such as the CAT, have 
value for both patients and providers in daily practice 
and can be an important tool in creating a dialogue 
Figure 2.  Comparison of patient COPD Assessment Test categories and physician assessment of chronic 
obstructive pulmonary disease (COPD) on well-being and daily life.
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between provider and patient. This study serves as 
an important pilot identifying a potential area for 
improvement in patient-provider communication in 
any clinic caring for patients with COPD.
Patient-Friendly Recap
•  Chronic obstructive pulmonary disease, or 
COPD, can be a deadly condition but also 
results in a range of serious symptoms that 
negatively affect patients’ lives.
•  The authors compared the responses of 
patients to questions on a COPD self-
assessment test with those of the patients’ 
physicians in a clinical setting.
•  They found that physicians often underestimate 
the presence of COPD symptoms and the 
disease’s impact on patients’ quality of life.
•  This discrepancy may be, in part, due to 
patients not realizing certain symptoms, like 
anxiety or poor sleep, can be related to COPD 
and should be reported as such.
Author Contributions 
Study design: Burchette, Click, Johnson, Williams. Data acquisition 
or analysis: Click, Williams, Morgan. Manuscript drafting: 
Burchette, Click, Johnson. Critical revision: Williams, Morgan.
Conflicts of Interest 
None.
References
1. American Lung Association. How serious is COPD: COPD 
prevalence, 2017. Last updated 2019 Apr 5. http://www.lung.
org/lung-health-and-diseases/lung-disease-lookup/copd/learn-
about-copd/how-serious-is-copd.html. Accessed April 8, 2019.
2. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. 
Chronic obstructive pulmonary disease surveillance--United 
States, 1971-2000. MMWR Surveill Summ. 2002;51(6):1-16.
3. Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final 
data for 2014. Natl Vital Stat Rep. 2016;65(4):1-122.
4. Kessler R, Partridge MR, Miravitlles M, et al. Symptom 
variability in patients with severe COPD: a pan-European 
cross-sectional study. Eur Respir J. 2011;37:264-72.  CrossRef
5. Gilbert C, Martin ML, Hareendran A. Capturing individual 
variation in the experience of symptoms reported by 
patients with COPD. (abstr.) Am J Respir Crit Care Med. 
2007;175:A15-A1004.
6. Miravitlles M, Ribera A. Understanding the impact of 
symptoms on the burden of COPD. Respir Res. 2017;18(1):67. 
CrossRef
7. Gardiner C, Gott M, Payne S, et al. Exploring the care needs of 
patients with advanced COPD: an overview of the literature. 
Respir Med. 2010;104:159-65.  CrossRef
8. Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, 
Kronish IM. Barriers to adherence to COPD guidelines 
among primary care providers. Respir Med. 2012;106:374-81. 
CrossRef
9. van der Molen T, Miravitlles M, Kocks JW. COPD management: 
role of symptom assessment in routine clinical practice. Int J 
Chron Obstruct Pulmon Dis. 2013;8:461-71.  CrossRef
10. Global Initiative for Chronic Obstructive Lung Disease 
(GOLD). Global Strategy for the Diagnosis, Management, 
and Prevention of Chronic Obstructive Pulmonary Disease 
(2018 Report). Fontana, WI: Global Initiative for Chronic 
Obstructive Lung Disease Inc, 2018, pp. 1-123.
11. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson 
NK. Health-related quality-of-life assessments and patient-
physician communication: a randomized controlled trial. 
JAMA. 2002;288:3027-34. CrossRef
12. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. 
Anxiety and depression – important psychological comorbidities 
of COPD. J Thorac Dis. 2014;6:1615-31.  CrossRef
13. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline 
Leidy N. Development and first validation of the COPD 
assessment test. Eur Respir J. 2009;34:648-54.  CrossRef
14. COPD Assessment Test: healthcare professional user guide. 
Issue 4 updated 2018 Nov. https://www.catestonline.org/
content/dam/global/catestonline/documents/CAT_HCP%20
User%20Guide.pdf. Accessed April 8, 2019.
15. GlaxoSmithKline plc. GSK, GOLD and the COPD Foundation 
announce formation of a new external expert Governance Board 
for the COPD Assessment Test (CAT). Press release dated 2014 
Sep 8. https://www.gsk.com/en-gb/media/press-releases/gsk-
gold-and-the-copd-foundation-announce-formation-of-a-new-
external-expert-governance-board-for-the-copd-assessment-
test-cat/. Accessed September 26, 2017.
16. Dury R. COPD and emotional distress: not always noticed and 
therefore untreated. Br J Community Nurs. 2016;21:138-41. 
CrossRef
17. Celli B, Blasi F, Gaga M, et al. Perception of symptoms and 
quality of life – comparison of patients’ and physicians’ views 
in the COPD MIRROR study. Int J Chron Obstruct Pulmon 
Dis. 2017;12:2189-96.  CrossRef
18. Miravitlles M, Ferrer J, Baro E, Lleonart M, Galera J. 
Differences between physician and patient in the perception 
of symptoms and their severity in COPD. Respir Med. 
2013;107:1977-85.  CrossRef
19. Bertakis KD, Azari R. Patient-centered care: the influence of 
patient and resident physician gender and gender concordance 
in primary care. J Womens Health (Larchmt). 2012;21:326-33. 
CrossRef
20. Roter DL, Hall JA, Aoki Y. Physician gender effects in medical 
communication: a meta-analytic review. JAMA. 2002;288:756-64. 
CrossRef
21. Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD 
assessment test: a systematic review. Eur Respir J. 
2014;44:873-84.  CrossRef
© 2019 Aurora Health Care, Inc.
